Catheter Site Discomfort Clinical Trial
Official title:
Clinical Study in Healthy Volunteers Evaluating the Performance and Handling of a Urinary Intermittent Catheter With a Newly Developed Swelling Media.
Verified date | August 2022 |
Source | Coloplast A/S |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Investigation of novel swelling media for CE marked intermittent urinary catheters. The study was a randomized, single blinded, cross-over investigation comparing a novel swelling media with a comparator swelling media in 22 adult, healthy, male volunteers.
Status | Completed |
Enrollment | 22 |
Est. completion date | November 28, 2019 |
Est. primary completion date | November 28, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Written informed consent given - Minimum 18 years of age and with full legal capacity - Male gender - Willing to refrain from using analgesics up to 24 hours prior to catheterization visits - Negative urine multistix analysis for erythrocytes (microscopic hematuria) - Negative urine multistix analysis for leukocytes and nitrite, or if positive, subsequent negative for bacterial growth in urine culture Exclusion Criteria: - Abnormalities, diseases or surgical procedures performed in the lower urinary tract - Symptoms of urinary tract infections (at least one of the following: frequent urination, stinging or pain at urination) - Participating in other clinical investigations related to urinary tracts system during this investigation (inclusion to termination) or previously participation in this investigation - Known hypersensitivity toward any of the investigational device |
Country | Name | City | State |
---|---|---|---|
Denmark | Urologisk klinik Afsnit 2112, Rigshospitalet, Denmark | Copenhagen | København Ø |
Lead Sponsor | Collaborator |
---|---|
Coloplast A/S |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Overall Discomfort During Nurse Catheterization | Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score. | Immediately after the procedure/catheterization, up to 5 min. | |
Secondary | Insertion Discomfort During Nurse Catheterization | Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score. | Immediately after the procedure/catheterization, up to 5 min. | |
Secondary | Withdrawal Discomfort During Nurse Catheterization | Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score. | Immediately after the procedure/catheterization, up to 5 min. | |
Secondary | Urination Discomfort After Catheterization | Discomfort measured for the entire catheterization procedure (performed by nurse), using the Visual Analogue Scale (VAS). The VAS is a tool used to rate the intensity of certain sensations and feelings, e.g. discomfort/pain. It is a straight line of 10 cm (in this case horizontal) with one end meaning no discomfort/pain (0 cm) and the other end meaning the worst discomfort/pain imaginable (10 cm). The subject visualizes and marks a point on the line that matches the amount of discomfort/pain experienced. A high score reflects a worse outcome than a lower score. | Immediately after first normal void, up to 5 min. | |
Secondary | Catheter Handling During Insertion | Nurse evaluation of how he/she experienced catheter insertion on a 5-point likert scale including the options: Very difficult, difficult, neither difficult nor easy, easy or very easy. | Immediately after the procedure/catheterization, up to 5 min. | |
Secondary | Catheter Handling During Withdrawal | Nurse evaluation of how he/she experienced catheter withdrawal on a 5-point likert scale including the options: Very difficult, difficult, neither difficult nor easy, easy or very easy. | Immediately after the procedure/catheterization, up to 5 min. | |
Secondary | Touch of Catheter Coating | Nurse evaluation of whether or not it was needed to touch the catheter coating during handling and/or catheterization (yes/no). | Immediately after the procedure/catheterization, up to 5 min. | |
Secondary | Visual Blood During Catheterization | Nurse evaluation of if he/she experienced visual blood on either the catheter or in the urine during catheterization (yes/no). | Immediately after the procedure/catheterization, up to 5 min. | |
Secondary | Microscopic Blood in Catheter-collected Urine | Dipstick analysis of hematuria (erythrocytes) after catheterization using a semi-quantitative color scale with five categories ranging from negative to 3+:
Negative (-). 10 erythrocytes/µL (+/-). 25 erythrocytes/µL (1+). 80 erythrocytes/µL (2+). 200 erythrocytes/µL (3+). At least one fully positive response (i.e., either 1+, 2+ or 3+), the endpoint was considered positive and the outcome was analyzed as a binary response (positive/negative). |
Immediately after the procedure/catheterization, up to 30 min. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02228473 -
Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort
|
N/A | |
Not yet recruiting |
NCT02252445 -
Propofol and Sevoflurane for Catheter-Related Bladder Discomfort
|
N/A | |
Terminated |
NCT03118284 -
Foley Catheter Related Bladder Discomfort (FCRBD): Role of Neutrophil Cells
|
||
Completed |
NCT02096224 -
Sevoflurane Versus Desflurane for Catheter-related Bladder Discomfort
|
N/A | |
Not yet recruiting |
NCT02683070 -
Pudendal Nerve Block for Catheter-related Bladder Discomfort Prevention
|
N/A | |
Recruiting |
NCT03199105 -
Preoperative Education With Image Illustrations Enhances Effect of Tetracaine Mucilage in Alleviating Postoperative CRBD
|
N/A | |
Recruiting |
NCT03072394 -
Local Anesthesia in Radial Catheterization
|
Phase 4 | |
Terminated |
NCT03976557 -
BIP CVC in Access Center at Danderyd Hospital, Stockholm, Sweden
|
N/A |